MedTrace Logo

S Protein and COVID-19: a Monocentric Prospective Study

NCT05351385 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2024-01-02

No results posted yet for this study

Summary

The aim of this study is to compare plasma S Protein levels to SARS-CoV-2 viral load in COVID positive patients.

Conditions

Interventions

PROCEDURE

Hematolgy and Chemistry analysis

Samples will be collected at Day 0, Day 5, Day 10 and Day 15

PROCEDURE

Real Time PCR

Samples will be collected at Day 0, Day 5, Day 10 and Day 15

PROCEDURE

PROS assay COVID+

Samples will be collected at Day 0, Day 5, Day 10 and Day 15

PROCEDURE

Sflt1 assay COVID+

Samples will be collected at Day 0 and Day 10

PROCEDURE

PROS assay CONTROL

Samples will be collected at Day 0 (+5)

PROCEDURE

Sflt1 assay CONTROL

Samples will be collected at Day 0 (+5)

Sponsors & Collaborators

  • San Gerardo Hospital

    collaborator OTHER

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Luisa Verga, MD · San Gerardo Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-23
Primary Completion
2022-06-03
Completion
2024-12-03

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05351385 on ClinicalTrials.gov